Disease Activity and Bone Mineral Density of MCP Joints in Patients with Rheumatoid and Psoriatic Arthritis: Is There a Correlation?—A Study in Patients Treated with Methotrexate and an Anti-TNFα Agent

Background. Bone damage in rheumatoid arthritis (RA) and in psoriatic arthritis (PsA) includes an accelerated bone mineral density (BMD) reduction. The objective was to evaluate BMD variations of the metacarpophalangeal joints (MCPs) in patients starting treatment with methotrexate (MTX) or etanerce...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertoldi, Ilaria, Filippou, Georgios, Scirè, Carlo Alberto, Picerno, Valentina, di Sabatino, Valentina, Adinolfi, Antonella, Pierguidi, Serena, Galeazzi, Mauro, Frediani, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871921/
https://www.ncbi.nlm.nih.gov/pubmed/24381766
http://dx.doi.org/10.1155/2013/708323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871921/
https://www.ncbi.nlm.nih.gov/pubmed/24381766
http://dx.doi.org/10.1155/2013/708323

Ejemplares similares